托珠单抗

ATC L04AC · 1 markets · 9 records

托珠单抗 1 markets · 9 records Forms
Filters
MarketCN 9

CN 9 records · 5 shown of 5 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 80 mg/4 mLinjection安维泰托珠单抗施瑞立、雅美罗
  • 80 mginjection安佰欣托珠单抗考普瑞宁
  • 400 mg/20 mLinjection施瑞立托珠单抗
  • 200 mg/10 mLinjection施瑞立托珠单抗
  • 162 mg/0.9 mLinjectionManufacturer: RocheRegislrationGmbH ×2
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.